1 |
Nonogaki, K., Strack, A.M., Dallman, M.F., and Tecott, L.H. (1998). Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat. Med. 4, 1152-1156.
DOI
|
2 |
Oh, C.M., Namkung, J., Go, Y., Shong, K.E., Kim, K., Kim, H., Park, B.Y., Lee, H.W., Jeon, Y.H., Song, J., et al. (2015). Regulation of systemic energy homeostasis by serotonin in adipose tissues. Nat. Commun. 6, 6794.
DOI
|
3 |
Ohara-Imaizumi, M., Kim, H., Yoshida, M., Fujiwara, T., Aoyagi, K., Toyofuku, Y., Nakamichi, Y., Nishiwaki, C., Okamura, T., and Uchida, T. (2013). Serotonin regulates glucose-stimulated insulin secretion from pancreatic cells during pregnancy. Proc. Natl. Acad. Sci. USA 110, 19420-19425.
DOI
|
4 |
Rothwell, N.J., and Stock, M.J. (1987). Effect of diet and fenfluramine on thermogenesis in the rat: possible involvement of serotonergic mechanisms. Int. J. Obes. 11, 319-324.
|
5 |
Sakaguchi, T., and Bray, G.A. (1989). Effect of norepinephrine, serotonin and tryptophan on the firing rate of sympathetic nerves. Brain Res. 492, 271-280.
DOI
|
6 |
Savelieva, K.V., Zhao, S., Pogorelov, V.M., Rajan, I., Yang, Q., Cullinan, E., and Lanthorn, T.H. (2008). Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 3, e3301.
DOI
|
7 |
Serretti, A., and Mandelli, L. (2010). Antidepressants and body weight: a comprehensive review and meta-analysis. J. Clin. Psychiatry 71, 1259-1272.
DOI
|
8 |
Sohn, J.W., Elmquist, J.K., and Williams, K.W. (2013). Neuronal circuits that regulate feeding behavior and metabolism. Trends Neurosci. 36, 504-512.
DOI
|
9 |
Sumara, G., Sumara, O., Kim, Jason K., and Karsenty, G. (2012). Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metab. 16, 588-600.
DOI
|
10 |
Tecott, L.H., Sun, L.M., Akana, S.F., Strack, A.M., Lowenstein, D.H., Dallman, M.F., and Julius, D. (1995). Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374, 542-546.
DOI
|
11 |
Uchida-Kitajima, S., Yamauchi, T., Takashina, Y., Okada-Iwabu, M., Iwabu, M., Ueki, K., and Kadowaki, T. (2008). 5-Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1 expression in adipose tissue. FEBS Lett. 582, 3037-3044.
DOI
|
12 |
Vickers, S.P., Clifton, P.G., Dourish, C.T., and Tecott, L.H. (1999). Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice. Psychopharmacology 143, 309-314.
DOI
|
13 |
Wade, P.R., Chen, J., Jaffe, B., Kassem, I.S., Blakely, R.D., and Gershon, M.D. (1996). Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J. Neurosci. 16, 2352-2364.
DOI
|
14 |
Walther, D.J., and Bader, M. (2003). A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 66, 1673-1680.
DOI
|
15 |
Watanabe, H., Akasaka, D., Ogasawara, H., Sato, K., Miyake, M., Saito, K., Takahashi, Y., Kanaya, T., Takakura, I., Hondo, T., et al. (2010). Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover. Endocrinology 151, 4776-4786.
DOI
|
16 |
Yadav, V.K., Ryu, J.H., Suda, N., Tanaka, K.F., Gingrich, J.A., Schutz, G., Glorieux, F.H., Chiang, C.Y., Zajac, J.D., Insogna, K.L., et al. (2008). Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135, 825-837.
DOI
|
17 |
Zhou, L., Sutton, G.M., Rochford, J.J., Semple, R.K., Lam, D.D., Oksanen, Laura J., Thornton-Jones, Z.D., Clifton, P.G., Yueh, C.-Y., Evans, M.L., et al. (2007). Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 6, 398-405.
DOI
|
18 |
Yamakawa, J., Takahashi, T., Itoh, T., Kusaka, K., Kawaura, K., Wang, X.Q., and Kanda, T. (2003). A novel serotonin blocker, sarpogrelate, increases circulating adiponectin levels in diabetic patients with arteriosclerosis obliterans. Diabetes Care 26, 2477-2478.
DOI
|
19 |
Young, S.N., and Leyton, M. (2002). The role of serotonin in human mood and social interaction: Insight from altered tryptophan levels. Pharmacol. Biochem. Behav. 71, 857-865.
DOI
|
20 |
Zhang, X., Beaulieu, J.M., Sotnikova, T.D., Gainetdinov, R.R., and Caron, M.G. (2004). Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305, 217.
DOI
|
21 |
Bouwknecht, J.A., van der Gugten, J., Hijzen, T.H., Maes, R.A., Hen, R., and Olivier, B. (2001). Male and female 5-HT(1B) receptor knockout mice have higher body weights than wildtypes. Physiol. Behav. 74, 507-516.
DOI
|
22 |
Alenina, N., Kikic, D., Todiras, M., Mosienko, V., Qadri, F., Plehm, R., Boye, P., Vilianovitch, L., Sohr, R., Tenner, K., et al. (2009). Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc. Natl. Acad. Sci. USA 106, 10332-10337.
DOI
|
23 |
Arase, K., Sakaguchi, T., and Bray, G.A. (1988). Effect of fenfluramine on sympathetic firing rate. Pharmacol. Biochem. Behav. 29, 675-680.
DOI
|
24 |
Bertrand, R.L., Senadheera, S., Markus, I., Liu, L., Howitt, L., Chen, H., Murphy, T.V., Sandow, S.L., and Bertrand, P.P. (2011). A Western diet increases serotonin availability in rat small intestine. Endocrinology 152, 36-47.
DOI
|
25 |
Brand, T., and Anderson, G.M. (2011). The measurement of plateletpoor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin. Chem. 57, 1376-1386.
DOI
|
26 |
Breisch, S.T., Zemlan, F.P., and Hoebel, B.G. (1976). Hyperphagia and obesity following serotonin depletion by intraventricular pchlorophenylalanine. Science 192, 382-385.
DOI
|
27 |
Collins, S., Yehuda-Shnaidman, E., and Wang, H. (2010). Positive and negative control of Ucp1 gene transcription and the role of [beta]-adrenergic signaling networks. Int. J. Obes. 34, S28-S33.
DOI
|
28 |
Feldman, J.M. (1988). Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice. Behav. Brain Res. 29, 147-158.
DOI
|
29 |
Colman, E., Golden, J., Roberts, M., Egan, A., Weaver, J., and Rosebraugh, C. (2012). The FDA's assessment of two drugs for chronic weight management. N Eng. J. Med. 367, 1577-1579.
DOI
|
30 |
Crane, J.D., Palanivel, R., Mottillo, E.P., Bujak, A.L., Wang, H., Ford, R.J., Collins, A., Blumer, R.M., Fullerton, M.D., Yabut, J.M., et al. (2015). Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat. Med. 21, 166-172.
DOI
|
31 |
Gershon, M.D., and Ross, L.L. (1966). Location of sites of 5-hydroxytryptamine storage and metabolism by radioautography. J. Physiol. 186, 477-492.
DOI
|
32 |
Gershon, M.D., and Tack, J. (2007). The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397-414.
DOI
|
33 |
Gres, S., Canteiro, S., Mercader, J., and Carpene, C. (2013). Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells. Mol. Nutr. Food Res. 57, 1089-1099.
DOI
|
34 |
Gutknecht, L., Araragi, N., Merker, S., Waider, J., Sommerlandt, F.M., Mlinar, B., Baccini, G., Mayer, U., Proft, F., Hamon, M., et al. (2012). Impacts of brain serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic specification. PLoS One 7, e43157.
DOI
|
35 |
Halford, J.C.G., and Blundell, J.E. (1996). The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence. Physiol. Behav. 60, 933-939.
DOI
|
36 |
Heisler, L.K., Kanarek, R.B., and Gerstein, A. (1997). Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats. Pharmacol. Biochem. Behav. 58, 767-773.
DOI
|
37 |
Hannon, J., and Hoyer, D. (2008). Molecular biology of 5-HT receptors. Behav. Brain Res. 195, 198-213.
DOI
|
38 |
Haub, S., Ritze, Y., Ladel, I., Saum, K., Hubert, A., Spruss, A., Trautwein, C., and Bischoff, S.C. (2011). Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice. J. Pharmacol. Exp. Ther. 339, 790-798.
DOI
|
39 |
Heal, D.J., Aspley, S., Prow, M.R., Jackson, H.C., Martin, K.F., and Cheetham, S.C. (1998). Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int. J. Obes. Relat. Metab. Disord. 22 Suppl 1, S18-28; discussion S29.
|
40 |
Heisler, L.K., Cowley, M.A., Tecott, L.H., Fan, W., Low, M.J., Smart, J.L., Rubinstein, M., Tatro, J.B., Marcus, J.N., Holstege, H., et al. (2002). Activation of central melanocortin pathways by fenfluramine. Science 297, 609-611.
DOI
|
41 |
Kennett, G.A., and Curzon, G. (1988). Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) 96, 93-100.
DOI
|
42 |
Keszthelyi, D., Troost, F.J., and Masclee, A.A.M. (2009). Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol. Motil. 21, 1239-1249.
DOI
|
43 |
Kim, H., Toyofuku, Y., Lynn, F.C., Chak, E., Uchida, T., Mizukami, H., Fujitani, Y., Kawamori, R., Miyatsuka, T., Kosaka, Y., et al. (2010). Serotonin regulates pancreatic beta cell mass during pregnancy. Nat. Med. 16, 804-808.
DOI
|
44 |
Lam, D.D., and Heisler, L.K. (2007). Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Exp. Rev. Mol. Med. 9, 1-24.
|
45 |
Kim, H.J., Kim, J.H., Noh, S., Hur, H.J., Sung, M.J., Hwang, J.T., Park, J.H., Yang, H.J., Kim, M.S., Kwon, D.Y., et al. (2011). Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Proteome Res. 10, 722-731.
DOI
|
46 |
Kim, K., Oh, C.M., Ohara-Imaizumi, M., Park, S., Namkung, J., Yadav, V.K., Tamarina, N.A., Roe, M.W., Philipson, L.H., Karsenty, G., et al. (2015). Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state. Endocrinology 156, 444-452.
DOI
|
47 |
Kinoshita, M., Ono, K., Horie, T., Nagao, K., Nishi, H., Kuwabara, Y., Takanabe-Mori, R., Hasegawa, K., Kita, T., and Kimura, T. (2010). Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol. Endocrinol. 24, 1978-1987.
DOI
|
48 |
Lam, D.D., Przydzial, M.J., Ridley, S.H., Yeo, G.S.H., Rochford, J.J., O'Rahilly, S., and Heisler, L.K. (2008). Serotonin 5-HT2C receptor agonist rromotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149, 1323-1328.
DOI
|
49 |
Lam, D.D., Garfield, A.S., Marston, O.J., Shaw, J., and Heisler, L.K. (2010). Brain serotonin system in the coordination of food intake and body weight. Pharmacol. Biochem. Behav. 97, 84-91.
DOI
|
50 |
Le Feuvre, R.A., Aisenthal, L., and Rothwell, N.J. (1991). Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds. Brain Res. 555, 245-250.
DOI
|
51 |
Merens, W., Willem Van der Does, A.J., and Spinhoven, P. (2007). The effects of serotonin manipulations on emotional information processing and mood. J. Affect. Disord. 103, 43-62.
DOI
|
52 |
Lesurtel, M., Graf, R., Aleil, B., Walther, D.J., Tian, Y., Jochum, W., Gachet, C., Bader, M., and Clavien, P.A. (2006). Platelet-derived serotonin mediates liver regeneration. Science 312, 104-107.
DOI
|
53 |
Martin, C.K., Redman, L.M., Zhang, J., Sanchez, M., Anderson, C.M., Smith, S.R., and Ravussin, E. (2010). Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure. J. Clin. Endocrinol. Metab. 96, 837-845.
|
54 |
Matsuda, M., Imaoka, T., Vomachka, A.J., Gudelsky, G.A., Hou, Z., Mistry, M., Bailey, J.P., Nieport, K.M., Walther, D.J., Bader, M., et al. (2004). Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev. Cell 6, 193-203.
DOI
|
55 |
Monti, J.M. (2011). Serotonin control of sleep-wake behavior. Sleep Med. Rev. 15, 269-281.
DOI
|
56 |
Moore, M.C., DiCostanzo, C.A., Dardevet, D., Lautz, M., Farmer, B., Neal, D.W., and Cherrington, A.D. (2004). Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 287, E1057-1063.
DOI
|
57 |
Murphy, D.L., and Lesch, K.P. (2008). Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 9, 85-96.
|
58 |
Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., and Iwasaka, T. (2005). 5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes. Blood Coagul. Fibrinolysis 16, 423-428.
DOI
|